Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review

In conclusion, treatment of CHB with NAs is safe, with a low incidence of AEs. Despite the general understanding TAF being safer than TDF, the number of patients treated with TAF still is too small in comparison to other NAs to consolidate an accurate safety profile. PROSPERO Registration No. CRD42018086471
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research